| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 102507-85-7 | (Z)-2-(2-氨基噻唑-4-基)-2-(1-羧基-1-甲基)乙氧亞氨基乙酸 | (Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid; (Z)-2-(2-AMINOTHIAZOL-4-YL)-2-(2-T-BUTOXYCARBONYLMETHOXYIMINO)ACETIC ACID; (Z)-2-(2-AMINOTHIAZOL-4-YL)-2-(T-BUTOXYCARBONYLMETHOXYIMINO)ACETIC ACID; (Z)-2-(TERT-BUTOXYCARBONYL METHOXYIMINO)-2-(2-AMINOTHIAZOL-4-YL)ACETIC ACID; ATCA:( Z )-2-(2-AMINOTHIAZOL-4-YL)-2-(1-CARBOXY-1-METHYL)ETHOXYIMINOACETIC ACID; (Z)-2-(2-Aminothiazol-4-yl)-2-(l-Carboxy-l-Methyl)Ethoxyimino Acetic Acid; ( Z )-2-(2-AMINOTHIAZOL-4-YL)-2-(1-CARBOXY-1-METHYL)ETHOXYIMINOACETIC ACID (ATCA); (Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |  | C9H11N3O5S | 詳情 | 供應商 |
| 122384-88-7 | 糖尿病相關肽(胰島淀粉樣肽)(抗原) | AMYLIN, HUMAN; KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (DISULFIDE BRIDGE: 2-7); LYS-CYS-ASN-THR-ALA-THR-CYS-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2; DIABETES ASSOCIATED PEPTIDE AMIDE HUMAN; DIABETES-ASSOCIATED PEPTIDE (DAP) AMIDE, HUMAN; DIABETES-ASSOCIATED PEPTIDE HUMAN; DAP (HUMAN); DAP AMIDE, HUMAN; DAP |  | C8H17O3 * | 詳情 | 供應商 |